Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Ghebrenegus AS"'
Publikováno v:
Drug, Healthcare and Patient Safety, Vol Volume 12, Pp 145-149 (2020)
Mulugeta Russom,1 Aziza Afendi,1 Amon Solomon Ghebrenegus1,2 1Eritrean Pharmacovigilance Centre, National Medicines and Food Administration, Asmara, Eritrea; 2Biet-Mekae Community Hospital, Asmara, EritreaCorrespondence: Mulugeta RussomEritrean Pharm
Externí odkaz:
https://doaj.org/article/40e5c6db779d4330aa4daa35a48506bf
Autor:
Merhawi Bahta, Natnael Russom, Amon Solomon Ghebrenegus, Yohana Tecleab Okubamichael, Mulugeta Russom
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 4, Pp 735-744 (2024)
Abstract Introduction The association between omeprazole and hypertension is poorly documented. The summary of product characteristics of omeprazole approved by major regulators did not mention hypertension as an adverse drug event. Triggered by a lo
Externí odkaz:
https://doaj.org/article/230ea82646ab4308b45d524f481b5f13
Autor:
Merhawi Bahta, Natnael Russom, Amon Solomon Ghebrenegus, Yohana Tecleab Okubamichael, Mulugeta Russom
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 4, Pp 745-745 (2024)
Externí odkaz:
https://doaj.org/article/98ac902a6a9442289796091e4fe6f057
Autor:
Samuel Tekle Mengistu, Ghirmay Ghebrekidan Ghebremeskel, Hermon Berhe Ghebrat, Oliver Okoth Achila, Nahom Asmerom Yohannes, Amon Solomon Ghebrenegus, Filmon Ghebretsadik Wendmhuney, Naod Yeibyo, Amanuel Kidane Andegiorgish, Araia Berhane Mesfin, Negassi Leake
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-14 (2022)
Key summary points Why carry out this study? The lack of data regarding the magnitude and possible risk factors for TF in Eritrea makes it difficult to formulate evidence-based improvements in patient management. This study has identified important d
Externí odkaz:
https://doaj.org/article/39b92e80235447aca9a934048c60f553
Autor:
Bahta, Merhawi, Russom, Natnael, Ghebrenegus, Amon Solomon, Okubamichael, Yohana Tecleab, Russom, Mulugeta
Publikováno v:
Drugs - Real World Outcomes; Dec2024, Vol. 11 Issue 4, p735-744, 10p
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Antibiotic resistance due to overuse of antimicrobials is an issue that has been of concern to many health institutions and society in general. Resistant infections have high impact in low income countries since they can’t affor
Externí odkaz:
https://doaj.org/article/1fa68824b7bc465e87a9724ab1703688
Autor:
Henok Woldu, Sirak Tesfamariam, Mulugeta Russom, Amon Solomon Ghebrenegus, Ephrem Fisseha, Gebremeskel Belai
Publikováno v:
BMJ Open Respiratory Research, Vol 8, Iss 1 (2021)
Background Multidrug-resistant tuberculosis (MDR-TB) drugs have never been associated with erythrocytosis. In Eritrea, however, several cases of incident erythrocytosis had been observed in the MDR-TB hospital. This study was aimed at exploring the a
Externí odkaz:
https://doaj.org/article/443fb9531cde449f974f372716bdaa50
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amon Solomon Ghebrenegus, Habtom Kifle, Merhawi Debesai, Mulugeta Russom, Dawit Tesfai, Iyassu Bahta
Publikováno v:
International Journal of Risk & Safety in Medicine. 32:101-107
BACKGROUND: Ranitidine injection is not well-known to cause cardiac arrest except in few published case reports. The Eritrean Pharmacovigilance Centre received four cases of cardiac arrest associated with ranitidine injection. OBJECTIVE: To assess th
Publikováno v:
Drug, Healthcare and Patient Safety. 12:145-149
Background Penicillins have never been associated with any form of hearing disorders. The Eritrean Pharmacovigilance Centre recently received two cases of hearing disorder (including one case of deafness) following the intake of amoxicillin capsules.